← back to search

Mario Delia

Policlinico Universitario di Catania · IT
Area of research
Hematology · Infectious Diseases
Research interest
Research interests include Acute Myeloid Leukemia Research, Antifungal resistance and susceptibility, Fungal Infections and Studies, and Acute Lymphoblastic Leukemia research.
h-index
28
citations
2,927
works
146
NIH funding
primary concept
Medicine
email

Recent publications

Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey
International Journal of Antimicrobial Agents 2023cited by 31position: middledoi
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first‐line therapy with hypomethylating agents alone or in combination with Venetoclax
American Journal of Hematology 2023cited by 23position: middledoi
Posaconazole and midostaurin in patients with <scp>FLT3</scp>‐mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study
Clinical and Translational Science 2023cited by 6position: middledoi
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Blood 2022cited by 90position: middledoi
Outcome of infection with omicron <scp>SARS‐CoV</scp>‐2 variant in patients with hematological malignancies: An <scp>EPICOVIDEHA</scp> survey report
American Journal of Hematology 2022cited by 72position: middledoi
High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study
Journal of Fungi 2022cited by 14position: middledoi
P517: PROSPECTIVE MULTICENTRIC STUDY ON INFECTIOUS COMPLICATIONS AND CLINICAL OUTCOME IN 230 UNFIT AML PATIENTS TREATED IN FIRST-LINE WITH HYPOMETHYLATING AGENTS ALONE OR IN COMBINATION WITH VENETOCLAX.
HemaSphere 2022cited by 0position: middledoi
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T‐cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study
American Journal of Hematology 2020cited by 67position: middledoi
Do high MICs predict the outcome in invasive fusariosis?
Journal of Antimicrobial Chemotherapy 2020cited by 55position: middledoi
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey
PLoS ONE 2019cited by 47position: middledoi
A bronchoalveolar lavage‐driven antimicrobial treatment improves survival in hematologic malignancy patients with detected lung infiltrates: A prospective multicenter study of the SEIFEM group
American Journal of Hematology 2019cited by 26position: middledoi
Fungal infections of the central nervous system and paranasal sinuses in onco‐haematologic patients. Epidemiological study reporting the diagnostic‐therapeutic approach and outcome in 89 cases
Mycoses 2018cited by 77position: middledoi
Bloodstream infections caused by <i>Klebsiella pneumoniae</i> in onco‐hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey
American Journal of Hematology 2016cited by 147position: middledoi
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study)
Haematologica 2015cited by 79position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Alessandro Busca · Azienda Ospedaliera Citta' della Salute e della Scienza di Torino6 papers (2016–2023)Chiara Cattaneo · ASST Spedali Civili of Brescia6 papers (2016–2023)Livio Pagano · Centre Hospitalier de Versailles6 papers (2016–2023) · 6 papers (2016–2023) · 5 papers (2016–2023)Francesco Marchesi · Istituti di Ricovero e Cura a Carattere Scientifico5 papers (2019–2023) · 4 papers (2019–2023)Michelina Dargenio · Ospedale Vito Fazzi4 papers (2019–2023) · 4 papers (2016–2023)Mario Tumbarello · Policlinico San Matteo Fondazione4 papers (2016–2023) · 3 papers (2016–2023) · 3 papers (2019–2023) · 3 papers (2016–2023) · 2 papers (2019–2023)Daniele Armiento · Università Campus Bio-Medico2 papers (2019–2023) · 2 papers (2019–2023) · 2 papers (2019–2023)Nicola Fracchiolla · University of Milan2 papers (2022–2023) · 2 papers (2016–2019)Marica Laurino · University of Padua2 papers (2019–2023)